Drug Trial Radar · NCT01042730
Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)
Last checked: Nov 20, 2026Latest source record: May 17, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13,054
Actual
Start
Feb 2010
Primary completion
Jun 2016
Study completion Nov 2017
Sponsor
- Lead sponsor
- Juntendo UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Tokyo University; Yamaguchi University Hospital; Tohoku University; Kyoto University; Kumamoto University
- First posted
- Jan 6, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 20 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the prevention of cardiovascular disease by moderate cholesterol lowering therapy, pitavastatin 1mg/day or aggressive cholesterol lowering therapy, pitavastatin 4mg/day in patients with stable coronary artery disease.
Conditions
- Coronary Artery Disease
Interventions
Pitavastatin 1 mg daily or 4 mg dailyDrug
Patients who met all inclusion criteria and did not meet exclusion criteria (1) are entered in run-in period, loading pitavastatin 1 mg/day for more than 1 month when informed consent was given. (Primary registration) After 1 month, patients who did not meet exclusion criteria(2) are randomized to take pitavastatin 1 mg/day or 4 mg/day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of one of following events(Cardiovascular death, Non-fatal Myocardial Infarction (MI), Non-fatal Cerebral Infarction (CI), Unstable angina requiring urgent hospitalization)Time frame: 3-6 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Kyoto University Hospital
Kyoto, Japan
Juntendo University School of Medicine
Tokyo, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.